Article Information
History
- February 28, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Anna Irene Vedel Sørensen1,*,
- Lampros Spiliopoulos2,
- Peter Bager1,2,
- Nete Munk Nielsen2,3,
- Jørgen Vinsløv Hansen2,
- Anders Koch1,4,
- Inger Kristine Meder2,
- Steen Ethelberg1,4 and
- Anders Hviid2,5
- 1Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark
- 2Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
- 3Focused Research Unit in Neurology, Department of Neurology, Hospital of Southern Jutland, University of Southern Denmark, Denmark
- 4Department of Public Health, Global Health Section, University of Copenhagen, Copenhagen, Denmark
- 5Pharmacovigilance Research Centre, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark
- ↵*Correspondence to: aivs{at}ssi.dk
Posted February 28, 2022.
Post-acute symptoms, new onset diagnoses and health problems 6 to 12 months after SARS-CoV-2 infection: a nationwide questionnaire study in the adult Danish population
